Category Press Releases

L&T Technology Services and Databricks Join Forces to Scale Industrial AI for Asset-Intensive Industries

L&T Technology Services, Databricks Partner to Deliver Industrial AI at Scale for Asset-Intensive Industries L&T Technology Services a global leader in AI, Digital & ER&D Consulting Services, announced a strategic go-to-market partnership with Databricks, the leading Data and AI company, to…

Read MoreL&T Technology Services and Databricks Join Forces to Scale Industrial AI for Asset-Intensive Industries
Watchmaker to Unveil NGS Workflow and

Watchmaker to Unveil NGS Workflow and Sequencing Accuracy Innovations at ESHG 2026

Watchmaker to Unveil New Technologies Addressing NGS Workflow Bottlenecks and Sequencing Accuracy Challenges at ESHG 2026 Watchmaker Genomics, a leader in high-performance NGS workflow solutions, announced it will unveil two new technologies at the European Society of Human Genetics (ESHG)…

Read MoreWatchmaker to Unveil NGS Workflow and Sequencing Accuracy Innovations at ESHG 2026
Seek Labs Maps All 25 Viral Families with

Seek Labs Maps All 25 Viral Families with BioSeeker, Advancing Antiviral Discovery

Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, announced it has mapped CRISPR-addressable regions across 25 out…

Read MoreSeek Labs Maps All 25 Viral Families with BioSeeker, Advancing Antiviral Discovery
Onchilles Pharma Begins Phase 12 Trial of

Onchilles Pharma Begins Phase 1/2 Trial of N17350, Dosing First Patient with Advanced Solid Tumors

Onchilles Pharma Doses First Patient in Phase 1/2 Clinical Trial of N17350 for Advanced Solid Tumors Onchilles Pharma, a clinical-stage biotechnology company pioneering next-generation cytotoxic therapeutics that harness the ELANE pathway, today announced that the first patient has been dosed…

Read MoreOnchilles Pharma Begins Phase 1/2 Trial of N17350, Dosing First Patient with Advanced Solid Tumors
Announce

Nephrodite’s Holly Dialysis System Selected for FDA TAP Program

Nephrodite’s Holly™ Implantable Continuous Dialysis System Awarded Selection into FDA’s TAP to Accelerate Development and Patient Access Nephrodite, Inc., a medical device company developing an implantable, continuous renal replacement system, announced that its Holly™ system has been selected to participate in…

Read MoreNephrodite’s Holly Dialysis System Selected for FDA TAP Program
Wolters

Wolters Kluwer and RSNA Sign 10-Year Deal to Expand Global Access to Radiology Research Journals

Wolters Kluwer and Radiological Society of North America Establish 10-Year Agreement to Advance Global Access to Leading Radiology Research Journals Wolters Kluwer Health announced a new 10-year agreement to publish the Radiological Society of North America (RSNA) portfolio of five specialty journals…

Read MoreWolters Kluwer and RSNA Sign 10-Year Deal to Expand Global Access to Radiology Research Journals
Turn Therapeutics Inc. a clinical-stage biotechnology company focused on developing localized therapies for inflammatory and

Turn Therapeutics Reports GX-03 Activity in IL-36 Inflammatory Model Study Published in Journal of Dermatological Treatment

Turn Therapeutics Announces Peer-Reviewed Publication in Journal of Dermatological Treatment Highlighting GX-03 Activity in IL-36 Associated Inflammatory Model Turn Therapeutics Inc. a clinical-stage biotechnology company focused on developing localized therapies for inflammatory and infectious skin diseases, announced the publication of…

Read MoreTurn Therapeutics Reports GX-03 Activity in IL-36 Inflammatory Model Study Published in Journal of Dermatological Treatment
Octave Bioscience

Octave Bioscience Appoints Zachary Fernandes as VP to Expand Strategic Partnerships

Octave Bioscience Accelerates Precision Neurology Momentum, Appoints Zachary Fernandes as VP of Business Development to Scale Strategic Partnerships Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker-driven solutions for multiple sclerosis, Parkinson’s and other neurodegenerative diseases, today announced…

Read MoreOctave Bioscience Appoints Zachary Fernandes as VP to Expand Strategic Partnerships
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease

TFG-001 Demonstrates Superior Functionality and Reinnervation in Parkinson’s Disease

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, announced that it will present new preclinical data on TFG-001 at the 7th…

Read MoreTFG-001 Demonstrates Superior Functionality and Reinnervation in Parkinson’s Disease